Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

September 2025

Core topics in this month’s edition include:

  • ropinirole extended-release tablets - Drug Withdrawal
  • Subvenite® (lamotrigine) – New drug approval
  • Tremfya® (guselkumab) – Expanded indications

Download

Rx navigation